MedPath

Significance of WT1 mRNA in the clinical course of lower-risk myelodysplastic syndromes.

Not Applicable
Recruiting
Conditions
lower-risk myelodysplastic syndromes
Registration Number
JPRN-UMIN000017862
Lead Sponsor
Jichi Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Interventional,observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Impacts of the value of WT1 mRNA on 2 year overall survival
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath